Miroslaw Ferenc

Miroslaw Ferenc

Auto-generated profile, based on publicly available information

Miroslaw Ferenc

Universitäts-Herzzentrum Bad Krozingem , Bad Krozingen, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
DHDavid Hildick-Smith
David Hildick-Smith
MEMohaned Egred
Mohaned Egred
ABAdrian P. Banning
Adrian P. Banning
PBPhilippe Brunel
Philippe Brunel
MFMiroslaw Ferenc
Miroslaw Ferenc
YLYves Louvard
Yves Louvard
Patients with non-left-main coronary bifurcation lesions are usually best treated with a stepwise provisional approach. However, patients with true left main stem bifurcation lesions have been shown in one dedicated randomized study to benefit from systematic dual stent implantation. Four hundred and sixty-seven patients with true left main stem bifurcation lesions requiring intervention were recruited to the EBC MAIN study in 11 European countries. Patients were aged 71 ± 10 years; 77% were male. Patients were randomly allocated to a stepwise layered provisional strategy (n = 230) or a systematic dual stent approach (n = 237). The primary endpoint (a composite of death, myocardial infarction, and target lesion revascularization at 12 months) occurred in 14.7% of the stepwise provisional group vs. 17.7% of the systematic dual stent group (hazard ratio 0.8, 95% confidence interval 0.5–1.3; P = 0.34). Secondary endpoints were death (3.0% vs. 4.2%, P = 0.48), myocardial infarction (10.0% vs. 10.1%, P = 0.91), target lesion revascularization (6.1% vs. 9.3%, P = 0.16), and stent thrombosis (1.7% vs. 1.3%, P = 0.90), respectively. Procedure time, X-ray dose and consumables favoured the stepwise provisional approach. Symptomatic improvement was excellent and equal in each group. Among patients with true bifurcation left main stem stenosis requiring intervention, fewer major adverse cardiac events occurred with a stepwise layered provisional approach than with planned dual stenting, although the difference was not statistically significant. The stepwise provisional strategy should remain the default for distal left main stem bifurcation intervention. http://clinicaltrials.gov NCT02497014. Compared with a dual stent strategy, numerically (but not statistically) fewer major adverse cardiac events occurred with the stepwise provisional approach.

1 November 2017 in The American Journal of Cardiology
Verified
Journal Article
Closed access
ATAurel Toma
Aurel Toma
BSBarbara E. Stähli
Barbara E. Stähli
MGMichael Gick
Michael Gick
CGCatherine Gebhard
Catherine Gebhard
BKBeat Kaufmann
Beat Kaufmann
FNFranz-Josef Neumann
Franz-Josef Neumann

1 June 2017 in EuroIntervention
Verified
Journal Article
Closed access
ATAurel Toma
Aurel Toma
CGCatherine Gebhard
Catherine Gebhard
MGMichael Gick
Michael Gick
FAFadil Ademaj
Fadil Ademaj
BSBarbara Stähli
Barbara Stähli
HBHeinz Joachim Buettner
Heinz Joachim Buettner
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

25 June 2020 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MFMiroslaw Ferenc
Miroslaw Ferenc
FNFranz-Josef Neumann
Franz-Josef Neumann
This editorial refers to ‘Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial’, by J.J. Zhang et al., doi:10.1093/eurheartj/ehaa543.

1 August 2013 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MFM. Ferenc
M. Ferenc
HBH. J. Buettner
H. J. Buettner
MGM. Gick
M. Gick
FNF.- J. Neumann
F.- J. Neumann
Background: Rotablation is mostly used to enable stent implantation in severely calcified coronary lesions. There is a lack of long term data regarding the outcome after rotablation in severe calcified lesions with either failed balloon crossing or in case of failed balloon expansion. Methods: To assess the 1-year outcome of rotabloation in this setting, we analyzed 210 consecutive patients undergoing rotablation required for preparation of stent implantation in severely calcified coronary lesions. Complete 1-year follow-up data was available for all patients. Results: Patients were on average 71 years old. The reasons for rotablation were in 42% inability to cross the lesion with the balloon and in 58% inability to expand the balloon in severe calcified lesion. Sixteen % of patients needed rotablation during PCI for acute coronary syndrom (ACS). The procedural success was 99,5%. Drug eluting stents (DES) were implanted in 88%. The majority of patients received initial rotablation with 1,5 mm burr. Elevated troponin a day post rotablation was measured in 38% of patients and elevated creatine kinase (CK) in 12%. Target vessel revascularisation (TVR) after 1 year post index PCI was performed in 13,2% of patients. The combined endpoint of death and myocardial infarction (MI) as marker for safety was reached by 14,4%. Death during 1-year follow-up occurred in 10,4%. Conclusions: Rotablation as a part of lesion preparation for stent implantation in otherwise untreatable severe calcified coronary lesions is associated with high procedural success rate. One-year event rates, however, indicate that patients in need for bail-out rotablation represent a high risk subset.